INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 123 filers reported holding INTERSECT ENT INC in Q4 2021. The put-call ratio across all filers is 6.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,778,000 | -0.1% | 352,370 | -1.7% | 0.00% | 0.0% |
Q4 2021 | $9,787,000 | -2.6% | 358,364 | -3.0% | 0.00% | 0.0% |
Q3 2021 | $10,049,000 | -5.9% | 369,442 | -40.9% | 0.00% | 0.0% |
Q2 2021 | $10,679,000 | -22.7% | 624,875 | -5.6% | 0.00% | -25.0% |
Q1 2021 | $13,822,000 | -12.7% | 661,952 | -4.3% | 0.00% | -20.0% |
Q4 2020 | $15,840,000 | +61.2% | 691,703 | +14.8% | 0.01% | +25.0% |
Q3 2020 | $9,828,000 | +26.9% | 602,574 | +5.3% | 0.00% | +33.3% |
Q2 2020 | $7,745,000 | +11.9% | 572,062 | -2.1% | 0.00% | 0.0% |
Q1 2020 | $6,924,000 | -57.8% | 584,351 | -11.4% | 0.00% | -50.0% |
Q4 2019 | $16,414,000 | +67.0% | 659,210 | +14.1% | 0.01% | +50.0% |
Q3 2019 | $9,829,000 | -23.1% | 577,829 | +2.9% | 0.00% | -20.0% |
Q2 2019 | $12,782,000 | +403.6% | 561,617 | +728.7% | 0.01% | -68.8% |
Q2 2018 | $2,538,000 | +79.9% | 67,770 | +88.8% | 0.02% | +77.8% |
Q1 2018 | $1,411,000 | +42.0% | 35,893 | +17.0% | 0.01% | +50.0% |
Q4 2017 | $994,000 | – | 30,690 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |